Candonilimab drug page Clinical trials

Trials with Candonilimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
44Planned patients

Showing 1–1 of 1

Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
Finished Phase 2 44 patients NCT06455254

This study is a single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of Candonilimab (AK104) combined with Regorafenib for the treatment of MSS colorectal liver metastasis. Candonilimab (AK104) is a humani…

China Jul 2024 – Jun 2026 Interventional
Combined with: Regorafenib